William Moore Email & Phone Number
@viamet.com
3 phones found area 919
LinkedIn matched
Who is William Moore? Overview
A concise factual answer block for searchers comparing this professional profile.
William Moore is listed as President and CEO of Propella, an Astellas Company at Freelance, based in Pittsboro, North Carolina, United States. AeroLeads shows a work email signal at viamet.com, phone signal with area code 919, and a matched LinkedIn profile for William Moore.
William Moore previously worked as President and CEO at Propella, An Astellas Company and President, CEO and Director at Propella Therapeutics, Inc.. William Moore holds Doctor Of Philosophy - Phd, Chemistry from Brown University.
Email format at Freelance
This section adds company-level context without repeating William Moore's masked contact details.
AeroLeads found 1 current-domain work email signal for William Moore. Compare company email patterns before reaching out.
About William Moore
VALUE PROPOSITION► I deliver top business leadership results, with extensive experience serving as founder, President, CEO, Director, and Chief Scientific Officer of multiple innovative pharmaceutical development organizations.► My success is driven by my ability to recognize commercial opportunities and then drive development programs that meet the medical need and ROI expectations. SUMMARY► Engaging Executive possessing a winning blend of subject matter expertise / product planning skill; proven experience as R&D, operations, and commercial leader.► Leverages a unique mix of strategic and analytical expertise, consistently exceeding performance goals by building strong teams and aligning their efforts with value-creating organizational objectives. LEADERSHIP HIGHLIGHTS★ Led the spinout of Propella from Vizuri through the creation of multiple high-value pharmaceutical products that supported the formation of an independent stand-alone corporate entity.★ Conceived a 505(b)(2) low cost, risk mitigated, product development strategy that enables high investor return and accelerated product approval timelines.★ Was recruited to become CEO / Director of Vizuri Health Sciences, LLC, a family-owned Rx / OTC development company, following a retained consulting engagement with the Company.★ In 2018, filed Vizuri's 1st IND and completed a US Phase 2 OA pain management study.★ Launched Vizuri's first OTC product, topical PainBloc24®. ★ As Founder, CEO, and Director of Innocrin Pharmaceuticals, transformed early stage clinical program into high-value Phase 2-proven asset. In addition to securing $28M in private venture capital funding, secured an additional $3MM in funding from the National Cancer Institute and $1M in funding from the Prostate Cancer Foundation, positioning the Company for a 2018 exit.★ As Chief Scientific Officer at Viamet, drove preclinical oncology and anti-fungal programs to clinical proof-of-concept. resulting in the 2018 acquisition of Viamet's lead program ☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲☲Specialties: Operations Leadership, Strategic Planning, R&D, Sales, Marketing, Launch, Fund Raising, Investor Relations, Drug Discovery, Clinical Trials, Regulatory Affairs, Revenue Growth, Strategic Partnerships, Team Leadership
Listed skills include Drug Discovery, Drug Development, Clinical Development, Genomics, and 15 others.
William Moore's current company
Company context helps verify the profile and gives searchers a useful next step.
William Moore work experience
A career timeline built from the work history available for this profile.
President And Ceo
Current Currently leading the post-merger integration of Propella the Propella organization and programs into Astellas, including PRL-02 global development strategies
President, Ceo And Director
Successfully accomplished a highly successful investor exit and significant ROI through the acquisition of Propella by Astellas Pharma for approximately $175M cash up-front; deal was recognized by the Corporate Growth Association as the #1 transaction in the Washington, DC area in the $50-$250M category in 2023★ Provided a positive ROI multiple to the.
President, Ceo And Director
★ Co-invented PRL-02, a patented CYP17 lyase-selective inhibitor for the the treatment of treatment prostrate cancer, which to the creation and spinout of Propella Therapeutics from Vizuri.★ Filed the US IND for CGS-200-5, a topical prescription strength formulation of capsaicin for the the treatment of pain due to osteoarthritis of the knee. ★ Completed a.
Principal
★ Launched a consulting firm and built a book of business comprising investors, companies in the biotechnology and pharmaceutical verticals, and academic clients.★ Client engagements included work with a Health Sciences corporation to use its patented and proprietary formulation technologies to improve the efficacy or safety of existing medications.★.
Founder, Ceo, President, Director
★ As founding CEO, closed a $6M financing round in late 2014, enabling the spinout of Innocrin from Viamet Pharmaceuticals and then completed a $28M private equity financing round in 1Q2015.★ Secured approximately $3M in funding from the National Cancer Institute and $1M in funding from the Prostate Cancer Foundation.★ Managed the discovery, development.
Ceo, President, Director
2016 Company Pitch at CED Life Sciences Meeting
Chief Scientific Officer
★ Responsible for directing development nominations and discovery, preclinical safety and efficacy, and CMC and regulatory activities for oncology (VT-464) and antifungal (VT-1161, VT-1129, VT-1598) NCEs.★ Led teams of R&D and regulatory affairs professionals from discovery through Phase 2 development.★ Hosted conferences with major medical and scientific.
President
Description:★ Served the needs of corporate, financial, and academic clients in the areas of business development, R&D strategy, due diligence, and finance.★ Contributed to the launch of new start-up and spin-out businesses.★ Negotiated licenses, authoring business plans, and securing multimillion dollar rounds of Series A funding on behalf of clients.★.
Scientific Founder, Chief Scientific Officer And Vp Of R&D
★ Founded and evolved a 75-employee organization from a computational fragment-based, chemistry company into a clinical business dedicated to the discovery of cancer and inflammatory treatments.★ Directed legal affairs, business development, and R&D.★ Negotiated out-licensing deals with Amgen, Dow, Dupont, Eli Lilly, Ono, and.
Vp Of Target Discovery & Validation
★ Responsible for management and integration of 220-person genomics / genetics organization into cancer target discovery Division of public drug development organization★ Reorganized the Division into effective and collaborative teams while elevating individual scientist visibility and retaining key personnel★ Initiated and managed corporate alliances with.
Senior Director Of Biology
★ Scientific leadership role in support of R&D, new BD initiatives, fundraising, and an IPO★ Established molecular biology, protein expression, high through-put screening, genomics, enzymology groups and directed 40 scientists★ Was team leader for revenue-generating partnerships with Bayer, Bristol Meryers Squibb, Merck, Pharmacia-Upjohn, and SmithKline.
Senior Research Biochemist Ii,
★ Led anti-cancer and anti-hypercholesterolemia projects while reporting to the to the Head of Chemical Sciences★ Led research teams focused on focused on discovery of inhibitors of cholesterol biosynthetic pathway and cancer proteases
Assistant Professor, Biochemistry Department
★ Assistant professor in the Biochemistry Dept., research focused on the glutathione function and disregulation★ Hired as a post-doc within the competitive Winston Foundation Fellow program (Alton Meister, MD, mentor)
William Moore education
Doctor Of Philosophy - Phd, Chemistry
Ph.D., Chemistry
B.S., Chemistry
Bachelor Of Science - Bs, Chemistry
Frequently asked questions about William Moore
Quick answers generated from the profile data available on this page.
What company does William Moore work for?
William Moore works for Freelance.
What is William Moore's role at Freelance?
William Moore is listed as President and CEO of Propella, an Astellas Company at Freelance.
What is William Moore's email address?
AeroLeads has found 1 work email signal at @viamet.com for William Moore at Freelance.
What is William Moore's phone number?
AeroLeads has found 3 phone signal(s) with area code 919 for William Moore at Freelance.
Where is William Moore based?
William Moore is based in Pittsboro, North Carolina, United States while working with Freelance.
What companies has William Moore worked for?
William Moore has worked for Freelance, Propella, An Astellas Company, Propella Therapeutics, Inc., Vizuri Health Sciences, Llc, and Fearrington Bio Advisory, Llc.
How can I contact William Moore?
You can use AeroLeads to view verified contact signals for William Moore at Freelance, including work email, phone, and LinkedIn data when available.
What schools did William Moore attend?
William Moore holds Doctor Of Philosophy - Phd, Chemistry from Brown University.
What skills is William Moore known for?
William Moore is listed with skills including Drug Discovery, Drug Development, Clinical Development, Genomics, Cancer, Infectious Diseases, Pharmaceutical Industry, and Molecular Biology.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial